 LONDON-- BUSINESS WIRE --Silence Therapeutics plc, Nasdaq: SLN Silence or the Company, an experienced and innovative biotechnology company committed to transforming peoples lives by silencing diseases through precision engineered medicines, today announced that Craig Tooman, President and Chief Executive Officer of Silence, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12th at 9:45 a.m. PT. 